Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antianginal and antiulcer agents from Sankyo

Nov. 8, 1996

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Teva generic drug licensed by FDA

Nov. 8, 1996

Nycomed discontinues development of antihypertensive drug

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Antiarrhythmic 1,4-benzodiazepine from Merck

Nov. 1, 1996

Safer antiarrhythmic agent reported by Canadian researchers

Nov. 1, 1996

Hoechst claims new antiarrhythmic agents

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...